Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis

Japanese Journal of Clinical Immunology

Volumn 30, Issue 5, 2007, Pages 414-418

  Hirano, Toru ^a   Hagiharai, Keisuke ^a   Kawai, Mari ^a   Kuwahara, Yusuke ^a   Yamadori, Tomoki ^a   Shima, Yoshihito ^a   Ogata, Atsushi ^a   Tanaka, Toshio ^a   Yoshizaki, Kazuyuki ^b   Kawase, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

CNS lupus; Intravenous cyclophosphamide; Lupus myelitis

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISOLONE;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; DRUG PULSE THERAPY; FEMALE; HUMAN; MYELITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BRAIN DISEASES; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYELITIS; PREDNISOLONE; PULSE THERAPY, DRUG;

EID: 38449122044     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.30.414     Document Type: Article

References (13)

1. Kovacs, B., et al.: Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature. Ann. Rheum. Dis. 59: 120–124, 2000.
2. Tokunaga, M., et al.: Successful treatment of intravenous cyclophosphamide pulse therapy for lupus myelitis with urinary disturbance and acute confusional state. NihonRinshoMeneki Gakkai Kaishi. 27: 338–344, 2004.
3. Barile, L., et al.: Transverse myelitis in systemic lupus erythematosus- the effect of IV pulse methylprednisolone and cyclophosphamide. J. Rheumatol. 19: 370–372, 1992.
4. Berlanga, B., et al.: Response to intravenous cyclophosphamide treatment in lupus myelopathy. J. Rheumatol. 19: 829–830, 1992.
5. Barrile, L., et al.: Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann. Rheum. Dis. 64: 620–625, 2005.
6. Boumpas, DT., et al.: Acute transverse myelitis in systemic lupus erythematosus: Magnetic resonance imaging and review of the literature. J. Rheumatol. 17: 89–92, 1990.
7. Provenzale, JM., et al.: Lupus-related myelitis: Serial MR findings. Am.J.Neuroradiol. 15: 1911–1917, 1994.
8. Lavalle, C., et al.: Transverse myelitis: A manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J. Rheumatol. 17: 34–37, 1990.
9. Schantz, V., et al.: Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipids antibody syndrome. J. Rheumatol. 25: 1425–1428, 1998.
10. Smyth, AE., et al.: Transverse myelitis: A complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome. Ulster. Med. J. 65: 91–94, 1996.
11. Eber, T., et al.: Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: Myth or reality? Lupus. 14: 571–575, 2005.
12. A. Hirohata.: Central nervous system involvement in connective tissue disease. Nihon Rinsho Meneki Gakkai Kaishi. 27: 109–117, 2004.
13. Armstrong, DJ., et al.: SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody). Rheumatol. Int. 26: 771–772, 2006.